A pH-sensitive molecularly imprinted nanospheres/hydrogel composite as a coating for implantable biosensors

Biomaterials

Volumn 31, Issue 18, 2010, Pages 4944-4951

  Wang, Chunyan ^a   Javadi, Alireza ^a   Ghaffari, Mehdi ^a   Gong, Shaoqin ^b  

^a University of Wisconsin Milwaukee   (United States)

^b University of Wisconsin Madison   (United States)

Author keywords

Composite; Controlled release; Hydrogel; Molecularly imprinted nanospheres

Indexed keywords

2-HYDROXYETHYL METHACRYLATE; 2-METHACRYLOYLOXYETHYL PHOSPHORYLCHOLINE; ACIDIC MICROENVIRONMENT; COMPOSITE; CONTROLLED RELEASE; DEXAMETHASONES; EQUILIBRIUM WATER CONTENTS; IMPLANTABLE BIOSENSORS; IMPRINTED CAVITIES; LOADING LEVEL; MOLECULARLY IMPRINTED; MOLECULARLY IMPRINTED POLYMER; NON-IMPRINTED POLYMERS; PH RANGE; PH SENSITIVE; PH VALUE; PH-RESPONSIVE; PRECIPITATION POLYMERIZATIONS; PYRROLIDINONE; RELEASE BEHAVIORS; RELEASE EXPERIMENTS; RELEASE PROFILES; RELEASE RATE; SWELLING KINETICS; TEMPLATE MOLECULES; UV POLYMERIZATION;

BIOCOMPATIBILITY; BIOSENSORS; HYDROGELS; PATHOLOGY; PH EFFECTS; PLASTIC COATINGS; POLYMERIZATION; POLYMERS; POTENTIOMETRIC SENSORS; SWELLING; WATER CONTENT;

NANOSPHERES;

1 VINYL 2 PYRROLIDINONE; 2 METHACRYLOYLOXYETHYLPHOSPHORYLCHOLINE; DEXAMETHASONE SODIUM PHOSPHATE; NANOSPHERE; POLYMACON; POLYMER;

ARTICLE; BIOCOMPATIBILITY; BIOSENSOR; CHEMICAL INTERACTION; COMPOSITE MATERIAL; CONTROLLED DRUG RELEASE; HYDROGEL; MATERIAL COATING; PH; POLYMERIZATION; PRECIPITATION; PRIORITY JOURNAL; ULTRAVIOLET RADIATION; WATER CONTENT;

ANTI-INFLAMMATORY AGENTS; BIOSENSING TECHNIQUES; COATED MATERIALS, BIOCOMPATIBLE; DELAYED-ACTION PREPARATIONS; DEXAMETHASONE; HYDROGELS; HYDROGEN-ION CONCENTRATION; MOLECULAR IMPRINTING; NANOSPHERES;

EID: 77951975831     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.02.073     Document Type: Article

References (40)

1. Hickey T., Kreutzer D., Burgess D.J., Moussy F. Dexamethasone/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices. Biomaterials 2002, 23(7):1649-1656.
2. Patil S.D., Papadmitrakopoulos F., Burgess D.J. Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis. J Controlled Release 2007, 117(1):68-79.
3. Moussy Y., Hersh L., Dungel P. Distribution of [H-3]dexamethasone in rat subcutaneous tissue after delivery from osmotic pumps. Biotechnol Prog 2006, 22(3):819-824.
4. Galeska I., Kim T.K., Patil S.D., Bhardwaj U., Chatttopadhyay D., Papadimitrakopoulos F., et al. Controlled release of dexamethasone from PLGA microspheres embedded within polyacid-containing PVA hydrogels. AAPS J 2005, 7(1):E231-E240.
5. Liu X., Nakamura K., Lowman A.M. Composite hydrogels for sustained release of therapeutic agents. Soft Mater 2003, 1(3):393-408.
6. Eroglu H., Kas H.S., Oner L., Turkoglu O.F., Akalan N., Sargon M.F., et al. The in-vitro and in-vivo characterization of PLGA: L-PLA microspheres containing dexamethasone sodium phosphate. J Microencapsulation 2001, 18(5):603-612.
7. Gomez-Gaete C., Fattal E., Silva L., Besnard M., Tsapis N. Dexamethasone acetate encapsulation into trojan particles. J Controlled Release 2008, 128(1):41-49.
8. Gomez-Graete C., Tsapis N., Besnard M., Bochot A., Fattal E. Encapsulation of dexamethasone into biodegradable polymeric nanoparticles. Int J Pharm 2007, 331(2):153-159.
9. Jaraswekin S., Prakongpan S., Bodmeier R. Effect of poly(lactide-co-glycolide) molecular weight on the release of dexamethasone sodium phosphate from microparticles. J Microencapsulation 2007, 24(2):117-128.
10. Zolnik B.S., Burgess D.J. Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres. J Controlled Release 2008, 127(2):137-145.
11. Wang J.F., Cormack P.A.G., Sherrington D.C., Khoshdel E. Monodisperse, molecularly imprinted polymer microspheres prepared by precipitation polymerization for affinity separation applications. Angew Chem Int Ed 2003, 42(43):5336-5338.
12. Cunliffe D., Kirby A., Alexander C. Molecularly imprinted drug delivery systems. Adv Drug Deliv Rev 2005, 57(12):1836-1853.
13. Jansen E.J.P., Sladek R.E.J., Bahar H., Yaffe A., Gijbels M.J., Kuijer R., et al. Hydrophobicity as a design criterion for polymer scaffolds in bone tissue engineering. Biomaterials 2005, 26(21):4423-4431.
14. Ulubayram K., Tunc Y., Baykara E. Molecularly imprinted acrylic-based microspheres for colonic delivery of 5-aminosalicylic acid. J Optoelectron Adv Mater 2007, 9(11):3479-3483.
15. Del Sole R., Lazzoi M.R., Arnone M., Della Sala F., Cannoletta D., Vasapollo G. Experimental and computational studies on non-covalent imprinted microspheres as recognition system for nicotinamide molecules. Molecules 2009, 14(7):2632-2649.
16. Feng Q.-Z., Zhao L.-X., Chu B.-L., Yan W., Lin J.-M. Synthesis and binding site characteristics of 2.4.6-trichlorophenol-imprinted polymers. Anal Bioanal Chem 2008, 392:11.
17. Lai J.P., Yang M.L., Niessner R., Knopp D. Molecularly imprinted microspheres and nanospheres for di(2-ethylhexyl)phthalate prepared by precipitation polymerization. Anal Bioanal Chem 2007, 389(2):405-412.
18. Cacho C., Turiel E., Martin-Esteban A., Perez-Conde C., Camara C. Characterisation and quality assessment of binding sites on a propazine-imprinted polymer prepared by precipitation polymerisation. J Chromatog B 2004, 802(2):347-353.
19. Cirillo G., Iemma F., Puoci F., Parisi O.I., Curcio M., Spizzirri U.G., et al. Imprinted hydrophilic nanospheres as drug delivery systems for 5-fluorouracil sustained release. J Drug Target 2009, 17(1):72-77.
20. Puoci F., Iemma F., Cirillo G., Picci N., Matricardi P., Alhaique F. Molecularly imprinted polymers for 5-fluorouracil release in biological fluids. Molecules 2007, 12(4):805-814.
21. Butoescu N., Jordan O., Burdet P., Stadelmann P., Petri-Fink A., Hofmann H., et al. Dexamethasone-containing biodegradable superparamagnetic microparticles for intra-articular administration: physicochemical and magnetic properties, in vitro and in vivo drug release. Eur J Pharm Biopharm 2009, 72(3):529-538.
22. Kanekiyo Y., Naganawa R., Tao H. pH-responsive molecularly imprinted polymers. Angew Chem Int Ed 2003, 42(26):3014-3016.
23. Puoci F., Iemma E., Muzzalupo R., Spizzirri U.G., Trombino S., Cassano R., et al. Spherical molecularly imprinted polymers (SMIPs) via a novel precipitation polymerization in the controlled delivery of sulfasalazine. Macromol Biosci 2004, 4(1):22-26.
24. Vermeulen M., Giordano M., Trevani A.S., Sedlik C., Gamberale R., Fernandez-Calotti P., et al. Acidosis improves uptake of antigens and MHC class I-restricted presentation by dendritic cells. J Immunol 2004, 172(5):3196-3204.
25. Kim J., Chauhan A. Dexamethasone transport and ocular delivery from poly(hydroxyethyl methacrylate) gels. Int J Pharm 2008, 353(1-2):205-222.
26. Wang C., Yu B., Knudsen B., Harmon J., Moussy F., Moussy Y. Synthesis and performance of novel hydrogels coatings for implantable glucose sensors. Biomacromolecules 2008, 9(2):561-567.
27. Yu B.Z., Wang C.Y., Ju Y.M., West L., Harmon J., Moussy Y., et al. Use of hydrogel coating to improve the performance of implanted glucose sensors. Biosens Bioelectron 2008, 23(8):1278-1284.
28. Hamilton V., Yuan Y., Rigney D.A., Puckett A.D., Ong J.L., Yang Y., et al. Characterization of chitosan films and effects on fibroblast cell attachment and proliferation. J Mater Sci Mater Med 2006, 17(12):1373-1381.
29. Yang Y., Zhang S.F., Kingston M.A., Jones G., Wright G., Spencer S.A. Glucose sensor with improved haemocompatibility. Biosens Bioelectron 2000, 15(5-6):221-227.
30. Goda T., Matsuno R., Konno T., Takai M., Ishihara K. Protein adsorption resistance and oxygen permeability of chemically crosslinked phospholipid polymer hydrogel for ophthalmologic biomaterials. J Biomed Mater Res Part B 2009, 89B(1):184-190.
31. Lewis A., Tang Y.Q., Brocchini S., Choi J.W., Godwin A. Poly(2-methacryloyloxyethyl phosphorylcholine) for protein conjugation. Bioconjugate Chem 2008, 19(11):2144-2155.
32. Gobeil F., Juneau C., Plante S. Thrombus formation on guide wires during routine PTCA procedures: a scanning electron microscopic evaluation. Can J Cardiol 2002, 18(3):263-269.
33. Lewis A.L., Tolhurst L.A., Stratford P.W. Analysis of a phosphorylcholine-based polymer coating on a coronary stent pre- and post-implantation. Biomaterials 2002, 23(7):1697-1706.
34. De Somer F., Francois K., van Oeveren W., Poelaert J., De Wolf D., Ebels T., et al. Phosphorylcholine coating of extracorporeal circuits provides natural protection against blood activation by the material surface. Eur J Cardio-Thoracic Surgery 2000, 18(5):602-606.
35. Licameli G., Johnston P., Luz J., Daley J., Kenna M. Phosphorylcholine-coated antibiotic tympanostomy tubes: are post-tube placement complications reduced?. Int J Pediatr Otorhinolaryngol 2008, 72(9):1323-1328.
36. Chan K.H., Armstrong J., Withers S., Malik N., Cumberland D.C., Gunn J., et al. Vascular delivery of c-myc antisense from cationically modified phosphorylcholine coated stents. Biomaterials 2007, 28(6):1218-1224.
37. Sakurai R., Hongo Y., Yamasaki M., Honda Y., Bonneau H.N., Yock P.G., et al. Detailed intravascular ultrasound analysis of zotarolimus-eluting phosphorylcholine-coated cobalt-chromium alloy stent in de novo coronary lesions (results from the ENDEAVOR II trial). Am J Cardiol 2007, 100(5):818-823.
38. Robert C.C.R., Buri P.A., Peppas N.A. Effect of degree of crosslinking on water transport in polymer microparticles. J Appl Polym Sci 1985, 30(1):301-306.
39. Norton L.W., Tegnell E., Toporek S.S., Reichert W.M. In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings. Biomaterials 2005, 26(16):3285-3297.
40. Shin J.H., Schoenfisch M.H. Improving the biocompatibility of in vivo sensors via nitric oxide release. Analyst 2006, 131(5):609-615.